 BURLINGTON, N.C.--BUSINESS WIRE--Labcorp NYSE: LH, a leading global life sciences company, today announced that it received Emergency Use Authorization EUA from the U.S. Food and Drug Administration FDA for a combined home collection kit that detects COVID-19 and influenza AB simultaneously in individuals as young as 2 years of age. The kit will be available at no upfront cost to those who meet clinical guidelines, which may include experiencing symptoms, being exposed to someone with 